See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2016_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 41,107,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 37,000 |
| 2 | PropertyPlantAndEquipmentNet | 280,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 1,808,000 |
| 5 | LiabilitiesNoncurrent | 54,000 |
| 6 | remainder_Liabilities | 5,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,236,831 |
| 9 | ResearchAndDevelopmentExpense | 13,444,065 |
| 10 | remainder_Expenses | 116,915 |
| 11 | remainder_Revenues | 52,692 |
| 12 | remainder_NetIncome | 2,602,718 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 41,424,000 |
| 1 | Liabilities | 1,867,000 |
| 2 | Expenses | 19,797,811 |
| 3 | Revenues | 52,692 |
| 4 | StockholdersEquity | 39,557,000 |
| 5 | NetIncome | -17,142,401 |
| 6 | ComprehensiveNetIncome | -17,142,401 |
| 7 | BaseVar | 32,872,110 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.19 |
| 9 | EconomicCapitalRatio | 3.82 |